Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Osteoporosis 1Infertility, Female 1Infertility 1Coronary Disease 1Cardiovascular Diseases 1Breast Neoplasms 1Abortion, Spontaneous 1

Interventions

Clomiphene 13Metformin 7Menotropins 4Letrozole 4Chorionic Gonadotropin 3ulipristal acetate 2cetrorelix 2Triptorelin Pamoate 2Sperm Injections, Intracytoplasmic 2Liraglutide 2follitropin beta 1follitropin alfa 1Solutions 1Progestins 1Progesterone 1Prednisolone 1Oils 1Methylprednisolone 1Medroxyprogesterone Acetate 1Leuprolide 1Inositol 1Injections 1Gonadotropins 1Gonadotropin-Releasing Hormone 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Danazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Infertility × Progesterone × Clear all
NCT00805935 2012-01-27

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

Ferring Pharmaceuticals

Phase 4 Completed
110 enrolled 22 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡